HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
CRADD
CARD and death domain containing adaptor protein
Chromosome 12 Β· 12q22
NCBI Gene: 8738Ensembl: ENSG00000169372.13HGNC: HGNC:2340UniProt: B4DJT6
65PubMed Papers
21Diseases
0Drugs
8Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protease bindingprotein bindingprotein-macromolecule adaptor activitydeath domain bindingautosomal recessive non-syndromic intellectual disabilityosteoarthritisintellectual developmental disorder, autosomal recessive 80, with variant lissencephalyIntellectual disability
✦AI Summary

CRADD (CARD and death domain containing adaptor protein) is a dual-domain adaptor protein that plays crucial roles in apoptosis regulation and cortical development. The protein contains an N-terminal caspase recruitment domain (CARD) and a C-terminal death domain, enabling interactions with multiple apoptotic signaling molecules 1. CRADD's primary function involves forming the PIDDosome complex with PIDD1 and caspase-2, which activates caspase-2 and triggers apoptosis 2. Additionally, CRADD recruits caspase-2 to TNFR-1 signaling complexes through interactions with RIPK1 and TRADD, participating in tumor necrosis factor-mediated pathways 1. Beyond apoptosis, CRADD functions as an anti-inflammatory regulator in endothelial cells by negatively controlling BCL10-mediated responses to proinflammatory stimuli, thereby maintaining vascular barrier function 3. Clinically, CRADD mutations cause intellectual developmental disorder with variant lissencephaly, characterized by megalencephaly, pachygyria, and seizures 4 5. These mutations impair CRADD's ability to activate caspase-2, resulting in reduced neuronal apoptosis during brain development 4. The phenotype suggests that proper CRADD/caspase-2 signaling is essential for normal cortical gyration and cognitive development, with defective programmed cell death contributing to cortical malformations.

Sources cited
1
CRADD has dual-domain structure with CARD and death domains, interacts with caspase-2 and participates in TNF receptor signaling
PMID: 9044836
2
CRADD forms PIDDosome complex with PIDD1 and caspase-2 to induce apoptosis
PMID: 38552015
3
CRADD functions as anti-inflammatory regulator in endothelial cells by controlling BCL10-mediated responses
PMID: 24958727
4
CRADD mutations cause intellectual disability with lissencephaly and impair caspase-2 activation leading to reduced neuronal apoptosis
PMID: 27773430
5
CRADD mutations associated with intellectual disability, lissencephaly, and brain atrophy
PMID: 33647455
Disease Associationsβ“˜21
autosomal recessive non-syndromic intellectual disabilityOpen Targets
0.61Moderate
osteoarthritisOpen Targets
0.48Moderate
intellectual developmental disorder, autosomal recessive 80, with variant lissencephalyOpen Targets
0.46Moderate
Intellectual disabilityOpen Targets
0.46Moderate
osteoarthritis, kneeOpen Targets
0.43Moderate
atrial fibrillationOpen Targets
0.42Moderate
osteoarthritis, hipOpen Targets
0.40Weak
syndromic intellectual disabilityOpen Targets
0.37Weak
familial isolated arrhythmogenic right ventricular dysplasiaOpen Targets
0.34Weak
Moderate intellectual disabilityOpen Targets
0.33Weak
liver diseaseOpen Targets
0.29Weak
total joint arthroplastyOpen Targets
0.28Weak
joint diseaseOpen Targets
0.28Weak
medical procedureOpen Targets
0.28Weak
ArthropathyOpen Targets
0.28Weak
atrial flutterOpen Targets
0.27Weak
total knee arthroplastyOpen Targets
0.26Weak
keratoconusOpen Targets
0.26Weak
transient ischemic attackOpen Targets
0.24Weak
ShockOpen Targets
0.24Weak
Intellectual developmental disorder, autosomal recessive 34, with variant lissencephalyUniProt
Pathogenic Variants8
NM_003805.5(CRADD):c.509G>A (p.Arg170His)Pathogenic
Intellectual disability, autosomal recessive 34|Intellectual disability|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 170
NM_003805.5(CRADD):c.52_59del (p.Ala18fs)Pathogenic
not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 18
NM_003805.5(CRADD):c.393G>A (p.Trp131Ter)Pathogenic
Familial isolated arrhythmogenic right ventricular dysplasia|Intellectual disability, autosomal recessive 34
β˜…β˜…β˜†β˜†2024β†’ Residue 131
NM_003805.5(CRADD):c.50del (p.Gly17fs)Likely pathogenic
Intellectual disability, autosomal recessive 34
β˜…β˜†β˜†β˜†2024β†’ Residue 17
NM_003805.5(CRADD):c.2T>C (p.Met1Thr)Pathogenic
Intellectual disability
β˜…β˜†β˜†β˜†2020β†’ Residue 1
NM_003805.5(CRADD):c.298+59160delLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2020
NM_003805.5(CRADD):c.508C>T (p.Arg170Cys)Pathogenic
Intellectual disability, autosomal recessive 34
β˜†β˜†β˜†β˜†2021β†’ Residue 170
NM_003805.5(CRADD):c.2T>G (p.Met1Arg)Pathogenic
Moderate intellectual disability
β˜†β˜†β˜†β˜†β†’ Residue 1
View on ClinVar β†—
Related Genes
FADDProtein interaction100%APAF1Protein interaction97%CYFIP2Protein interaction93%TRADDProtein interaction81%CASP2Protein interaction73%MINDY3Protein interaction73%
Tissue Expression6 tissues
Heart
100%
Liver
87%
Lung
27%
Ovary
25%
Bone Marrow
24%
Brain
22%
Gene Interaction Network
Click a node to explore
CRADDFADDAPAF1CYFIP2TRADDCASP2MINDY3
PROTEIN STRUCTURE
Preparing viewer…
PDB2O71 Β· 2.00 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.00LoF Tolerant
pLIβ“˜
0.03Tolerant
Observed/Expected LoF0.55 [0.32–1.00]
RankingsWhere CRADD stands among ~20K protein-coding genes
  • #7,159of 20,598
    Most Researched65
  • #3,073of 5,498
    Most Pathogenic Variants8
  • #9,640of 17,882
    Most Constrained (LOEUF)1.00
Genes detectedCRADD
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP.
PMID: 9044836
Cancer Res Β· 1997
1.00
2
CRADD and cIAP1 antagonistically regulate caspase-9-mediated apoptosis in teleost.
PMID: 39233177
Int J Biol Macromol Β· 2024
0.90
3
A 500-kb YAC and BAC contig encompassing the high-growth deletion in mouse chromosome 10 and identification of the murine Raidd/Cradd gene in the candidate region.
PMID: 9806843
Genomics Β· 1998
0.80
4
The adaptor CRADD/RAIDD controls activation of endothelial cells by proinflammatory stimuli.
PMID: 24958727
J Biol Chem Β· 2014
0.70
5
Extra centrosomes delay DNA damage-driven tumorigenesis.
PMID: 38552015
Sci Adv Β· 2024
0.60